Oxidation-strengthened disulfide-bridged prodrug nanoplatforms with cascade facilitated drug release for synergetic photochemotherapy
One of the major barriers in utilizing prodrug nanocarriers for cancer therapy is the slow release of parent drug in tumors. Tumor cells generally display the higher oxidative level than normal cells, and also displayed the heterogeneity in terms of redox homeostasis level. We previously found that...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
KeAi Communications Co., Ltd.
2020-09-01
|
| Seri Bilgileri: | Asian Journal of Pharmaceutical Sciences |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S181808761930786X |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|